120 research outputs found
Allosteric Modulators of Class B G-Protein-Coupled Receptors
Class B GPCR’s are activated by peptide ligands, typically 30-40 amino acid residues, that are involved in major physiological functions such as glucose homeostasis (glucagon and glucagon-like peptide 1), calcium homeostasis and bone turnover (parathyroid hormone and calcitonin), and control of the stress axis (corticotropin-releasing factor). Peptide therapeutics have been developed targeting these receptors but development of nonpeptide ligands, enabling oral administration, has proved challenging. Allosteric modulation of these receptors provides a potential route to developing nonpeptide ligands that inhibit, activate, or potentiate activation of these receptors. Here the known mechanisms of allosteric modulators targeting Class B GPCR’s are reviewed, particularly nonpeptide antagonists of the corticotropin-releasing factor 1 receptor and allosteric enhancers of the glucagon-like peptide-1 receptor. Also discussed is the potential for antagonist ligands to operate by competitive inhibition of one of the peptide binding sites, analogous to the Charniere mechanism. These mechanisms are then used to discuss potential strategies and management of pharmacological complexity in the future development of allosteric modulators for Class B GPCR’s
An Event Structure Model for Probabilistic Concurrent Kleene Algebra
We give a new true-concurrent model for probabilistic concurrent Kleene
algebra. The model is based on probabilistic event structures, which combines
ideas from Katoen's work on probabilistic concurrency and Varacca's
probabilistic prime event structures. The event structures are compared with a
true-concurrent version of Segala's probabilistic simulation. Finally, the
algebraic properties of the model are summarised to the extent that they can be
used to derive techniques such as probabilistic rely/guarantee inference rules.Comment: Submitted and accepted for LPAR19 (2013
A robust semantics hides fewer errors
In this paper we explore how formal models are interpreted and to what degree meaning is captured in the formal semantics and to what degree it remains in the informal interpretation of the semantics. By applying a robust approach to the definition of refinement and semantics, favoured by the event-based community, to state-based theory we are able to move some aspects from the informal interpretation into the formal semantics
A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol
INTRODUCTION. Prostate cancer is common and the incidence is increasing, but more men are living longer after diagnosis, and die with their disease rather than of it. Nonetheless, specific and substantial physical, sexual, emotional and mental health problems often lead to a poor quality of life. Urology services increasingly struggle to cope with the demands of follow-up care, and primary care is likely to play the central role in long-term follow-up. The present phase II trial will evaluate the feasibility and acceptability of a nurse-led, person-centred psychoeducational intervention, delivered in community or primary care settings.
METHODS AND ANALYSIS. Prostate cancer survivors diagnosed in the past 9-48 months and currently biochemically stable will be identified from hospital records by their treating clinician. Eligible men would have either completed radical treatment, or would be followed up with prostate specific antigen monitoring and symptom reporting. We will recruit 120 patients who will be randomised to receive either an augmented form of usual care, or an additional nurse-led intervention for a period of 36 weeks. Following the health policy in Wales, the intervention is offered by a key worker, is promoting prudent healthcare and is using a holistic needs assessment. Outcome measures will assess physical symptoms, psychological well-being, confidence in managing own health and quality of life. Healthcare service use will be measured over 36 weeks. Feedback interviews with patients and clinicians will further inform the acceptability of the intervention. Recruitment, attrition, questionnaire completion rates and outcome measures variability will be assessed, and results will inform the design of a future phase III trial and accompanying economic evaluation.
ETHICS AND DISSEMINATION. Ethics approval was granted by Bangor University and North Wales REC (13/WA/0291). Results will be reported in peer-reviewed publications, at scientific conferences, and directly through national cancer and primary care networks.
TRIAL REGISTRATION NUMBER. ISRCTN 34516019
Maternal periconceptional and first trimester protein restriction in beef heifers: effects on maternal performance and early fetal growth
This study evaluated the effect of protein restriction during the periconception (PERI) and first trimester (POST) periods on maternal performance, physiology and early fetal growth. Yearling nulliparous heifers (n = 360) were individually fed a diet high or low in protein (HPeri and LPeri respectively) beginning 60 days before conception. From 24 to 98 days post-conception (dpc), half of each treatment group changed to the alternative post-conception high- or low-protein diet (HPost and LPost respectively), yielding four groups in a 2 × 2 factorial design with a common diet until parturition. Protein restriction was associated with lower bodyweight subsequent to reduced (but positive) average daily weight gain (ADG) during the PERI and POST periods. During the POST period, ADG was greater in LPeri than HPeri heifers and tended to be greater in LPost than HPost heifers during the second and third trimester. Bodyweight was similar at term. The pregnancy rate did not differ, but embryo loss between 23 and 36 dpc tended to be greater in LPeri than HPeri heifers. Overall, a greater proportion of male fetuses was detected (at 60 dpc 63.3% male vs 36.7% female). Protein restriction altered maternal plasma urea, non-esterified fatty acids, progesterone, leptin and insulin-like growth factor 1 at critical stages of fetal development. However, profiles varied depending on the sex of the conceptus.Katrina J. Copping, Andrew Hoare, I. Caroline McMillen, Raymond J. Rodgers, Charles R. Wallace and Viv E.A. Perr
Multibeam Maser Survey of methanol and excited OH in the Magellanic clouds: new detections and maser abundance estimates
‘The definitive version is available at www.blackwell-synergy.com.’ Copyright Blackwell Publishing DOI: 10.1111/j.1365-2966.2008.12888.xPeer reviewe
Testing Reactive Probabilistic Processes
We define a testing equivalence in the spirit of De Nicola and Hennessy for
reactive probabilistic processes, i.e. for processes where the internal
nondeterminism is due to random behaviour. We characterize the testing
equivalence in terms of ready-traces. From the characterization it follows that
the equivalence is insensitive to the exact moment in time in which an internal
probabilistic choice occurs, which is inherent from the original testing
equivalence of De Nicola and Hennessy. We also show decidability of the testing
equivalence for finite systems for which the complete model may not be known
Crystal structure, electronic, and magnetic properties of the bilayered rhodium oxide Sr3Rh2O7
The bilayered rhodium oxide Sr3Rh2O7 was synthesized by high-pressure and
high-temperature heating techniques. The single-phase polycrystalline sample of
Sr3Rh2O7 was characterized by measurements of magnetic susceptibility,
electrical resistivity, specific heat, and thermopower. The structural
characteristics were investigated by powder neutron diffraction study. The
rhodium oxide Sr3Rh2O7 [Bbcb, a = 5.4744(8) A, b = 5.4716(9) A, c = 20.875(2)
A] is isostructural to the metamagnetic metal Sr3Ru2O7, with five 4d electrons
per Rh, which is electronically equivalent to the hypothetic bilayered
ruthenium oxide, where one electron per Ru is doped into the Ru-327 unit. The
present data show the rhodium oxide Sr3Rh2O7 to be metallic with enhanced
paramagnetism, similar to Sr3Ru2O7. However, neither manifest contributions
from spin fluctuations nor any traces of a metamagnetic transition were found
within the studied range from 2 K to 390 K below 70 kOe.Comment: To be published in PR
- …